|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4545 | (2006.01) |
| A61K 31/4545 | (2013.01) | ||
| A61K 31/5025 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07D 237/00 | (2013.01) | ||
| C07D 237/00 | (2006.01) | ||
| C07D 405/14 | (2013.01) | ||
| C07D 405/14 | (2006.01) | ||
| A61K 31/5025 | (2013.01) |
| (11) | Number of the document | 3626239 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18802340.2 |
| Date of filing the European patent application | 2018-05-17 | |
| (97) | Date of publication of the European application | 2020-03-25 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2018/087246 |
| Date | 2018-05-17 |
| (87) | Number | WO 2018/210296 |
| Date | 2018-11-22 |
| (30) | Number | Date | Country code |
| 201710350614 | 2017-05-18 | CN |
| (72) |
MA, Ke , CN
CAO, Guoqing , CN
YANG, Changyong , CN
ZHANG, Lianshan , CN
|
| (73) |
Jiangsu Hengrui Pharmaceuticals Co., Ltd. ,
No. 7 Kunlunshan Road
Economic and Technological Development Zone, Lianyungang, Jiangsu 222047,
CN
|
| (54) | EZH2 INHIBITOR COMBINED WITH BTK INHIBITOR FOR TREATING TUMOR |
| EZH2 INHIBITOR COMBINED WITH BTK INHIBITOR FOR TREATING TUMOR |